Ph.D., Genetics, Osmania University, Hyderabad (2004-2008).

a. January 2000 to May 2002: Research assistant for a project entitled “Impairment of nerve function in reaction in Leprosy,” Blue Peter Research centre, Lepra India, Hyderabad, India.
b. May 2002 to March 2006: Scientist at Virchow Biotech Private Limited Hyderabad, India.
c. March 2006 to April 2007: Visiting Scholar at Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
d. Nov 2007- May 2009: Post-Doctoral Fellow at Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
e. July 2009- till date: Assistant Professor, Dept. of Animal Sciences, Yogi Vemana University, KADAPA, India

Pulmonary Diseases ( asthma , fibrosis, cancer), Nuclear Receptors Signalling.

• CSIR: “Identification novel endogenous peroxisome proliferator-activated gamma (PPARγ) ligands in adipogenesis”. (2011-2014): 25 Lakh major research grant.
• Department of Science and Technology (DST-India), FAST TRACK Young Scientist, “Role of Nitrated fatty acids in immunosupression,” (2011-2014): 20 Lakh project.
• Department of Biotechnology (DBT): Role of Nuclear Receptors on airway inflammation and remodeling. (2011-2014): 50 lakh project
• Virchow Biotech Private Limited (VBPL), Hyderabad, “Study the role of NFAs on Lung fibrosis”. (2010- 2012): 10 Lakh funding.

1. Visiting Scholar Fellowship to work at University of Michigan, USA—Fellowship was sponsored by Virchow Biotech Private Limited, Hyderabad from 2006-2008.
2. Young scientist award (2011) from Department of Science and Technology (DST), India

1. Kanala JR, Panati K, Narala VR*. Efficient Recovery of Hyaluronic Acid from Highly Viscous Culture Broth. The IUP Journal of Life Sciences. 2011, 2: 15-20.*Corresponding author.

2. Reka AK, Kurapati H, Narala VR, Bommer G, Chen J, Standiford TJ, Keshamouni VG. Peroxisome Proliferator-Activated Receptor-γ Activation Inhibits Tumor Metastasis by Antagonizing Smad3-Mediated Epithelial-Mesenchymal Transition. Molecular Cancer Therapeutics. 2010 9:3221-3232.

3. Narala VR, Adapala RK, Brock TG, Peters-golden M, Reddy RC. Leukotriene B4 is a Physiologically Relevant Peroxisome Proliferator-Activated Receptor-a Agonist. Journal of Biological Chemistry. 2010, 16; 285(29):22067-74.

4. Smith MR, Gangireddy SR, Narala VR, Hogaboam CM, Standiford TJ, Kondapi AK, Reddy RC. Curcumin Inhibits Fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury. Am J Physiol Lung Cell Mol Physiol. 298:L616-L625.

5. Narala VR, Smith MR, Adapala RK, Ranga R, Panati K, Moore BB, Leff T, Reddy VD, Kondapi AK, Reddy RC. Curcumin is not a ligand for peroxisome proliferator-activated receptor-γ. Gene Ther Mol Biol.2009, 13: 20-25.

6. Reddy RC, Narala VR, Keshamouni VG, Milam JE, Newstead NW, Standiford TJ. Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-γ. Blood. 2008, 112(10):4250-4258.

7. Narala VR, Ranga R, Monica SR, Berlin AA, Standiford TJ, Lukacs NW, Reddy RC. Pioglitazone is as effective as dexamethasone in a murine model of cockroach allergen-induced asthma. Respir Research. 2007, 4; 8(1):90. [Highly Cited Designation];

8. Karumuri NN, Gangireddy SR, Narala VR, Majee SS, Gunwar S, Reddy RC. Simple, rapid, high-purity preparation of recombinant human platelet-derived growth factor-BB. Biotechnol Lett. 2007, 29(9):1333-1339.

9. Reddy PK, Reddy SG, Narala VR, Majee SS, Gunwar S, Reddy RC. Increased yield of high purity recombinant human interferon-gamma utilizing reversed phase column chromatography. Protein Exp Purif. 2007, 52(1):123-130.